Current Pharmaceutical Design
Title:Editorial (Thematic Issue: Future Trends in the Development of New Antidepressant Drugs)
Volume: 20 Issue: 23
Author(s): Angel Pazos
Affiliation:
Export Options
About this article
Cite this article as:
Pazos Angel, Editorial (Thematic Issue: Future Trends in the Development of New Antidepressant Drugs), Current Pharmaceutical Design 2014; 20 (23) . https://dx.doi.org/10.2174/13816128113196660742
DOI https://dx.doi.org/10.2174/13816128113196660742 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
38
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Immunology and Epilepsy: Clinical and Experimental Evidence
Current Immunology Reviews (Discontinued) Pharmacological Treatment of Obesity: Current Standards and Future Perspectives
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Classical and New Renin-Angiotensin Signalling in Atherosclerosis
Current Signal Transduction Therapy Central G-Protein Coupled Receptors (GPCR)s as Molecular Targets for the Treatment of Obesity: Assets, Liabilities and Development Status
Current Drug Targets - CNS & Neurological Disorders Contribution of Glucocorticoids and Glucocorticoid Receptors to the Regulation of Neurodegenerative Processes
CNS & Neurological Disorders - Drug Targets NPY Y2 and Y4 Receptors Selective Ligands: Promising Anti-Obesity Drugs?
Current Topics in Medicinal Chemistry Serum DHEA-S, Testosterone and Cortisol Levels in Female Patients with Schizophrenia
Endocrine, Metabolic & Immune Disorders - Drug Targets Adipose Tissue as a Regulator of Energy Balance
Current Drug Targets Recent Knowledge and New Pharmaceutical Products in Potential Alleviation of Endometriosis
Recent Patents on Inflammation & Allergy Drug Discovery Frailty of Older Age: The Role of the Endocrine - Immune Interaction
Current Pharmaceutical Design The Therapeutic Potential of Melatonin in Neurological Disorders
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Obesity Pharmacotherapy: Current Perspectives and Future Directions
Current Cardiology Reviews The Gender Bender effect in Periodontal Immune Response
Endocrine, Metabolic & Immune Disorders - Drug Targets Noradrenaline-mediated Inhibition of Inflammatory Cytokines is Altered in Macrophages from Obese Zucker Rats: Effect of Habitual Exercise
Endocrine, Metabolic & Immune Disorders - Drug Targets Pharmacomimetics of Exercise: Novel Approaches for Hippocampally- Targeted Neuroprotective Agents
Current Medicinal Chemistry Effects of Early Maternal Separation on Biobehavioral and Neuropathological Markers of Alzheimer's Disease in Adult Male Rats
Current Alzheimer Research Editorial: [Hot Topic: Non-Analgesic Effects of Opioids]
Current Pharmaceutical Design Cancer Cachexia: One Step Ahead
Reviews on Recent Clinical Trials Clomiphene Citrate, Metformin or Aromatase Inhibitors for Anovulatory Infertility in Women with Polycystic Ovary Syndrome (PCOS): A Systematic Review of Meta-analyses and Randomized Controlled Trials
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) Editorial Nutritional Therapy in Metabolic Syndrome
Current Vascular Pharmacology